Hypnotic use and the risk of cardiovascular diseases in insomnia patients - Top-Institutions - MDSpire

Hypnotic use and the risk of cardiovascular diseases in insomnia patients

  • By

  • Yao Xie

  • Shiyu Zhu

  • Shuang Wu

  • Chang Liu

  • Jian Shen

  • Chunna Jin

  • Hong Ma

  • Meixiang Xiang

  • August 7, 2024

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Sleep Medicine
    • Epidemiology
    • Genetic Epidemiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Sleep Medicine
    • Pharmacology

  • #3

    University of Oxford
    University of Oxford

    Oxford, UK

    Key Differentiators

    • Cardiovascular Epidemiology
    • Genetic Epidemiology
    • Sleep Medicine

  • #4

    Harvard Medical School / Brigham and Women's Hospital
    Harvard Medical School / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Sleep Medicine
    • Pharmacoepidemiology

  • #5

    Stanford University
    Stanford University

    Stanford, CA

    Key Differentiators

    • Cardiology
    • Sleep Medicine
    • Genomic Medicine

Original Source(s)

Hypnotic use and the risk of cardiovascular diseases in insomnia patients

  • by Yao Xie, Shiyu Zhu, Shuang Wu, Chang Liu, Jian Shen, Chunna Jin, Hong Ma, Meixiang Xiang

  • August 7, 2024

Related Content

Thoracoscopically assisted resection of left ventricular myxoma: a case report

Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care

Correction: Multicriteria Optimization of Language Models for Heart Failure With Preserved Ejection Fraction Symptom Detection in Spanish Electronic Health Records: Comparative Modeling Study